WASHINGTON, June 5, 2017 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it
will participate at the following upcoming investor conferences in
June 2017.
The Jefferies 2017 Global Healthcare Conference in New York City on Wednesday, June 7, 2017. A corporate presentation
is scheduled for 2:00 p.m. Eastern
Time.
The JMP Securities Life Sciences Conference in New York City on Tuesday, June 20, 2017.
The corporate presentation given at the Jefferies Healthcare
Conference will be available live on Vanda's corporate website,
where they also will be archived for 30 days. To access the
presentation, go to Vanda's website at www.vandapharma.com and
click on the Presentations tab on the Investor Relations page.
Please connect to the website several minutes prior to the start of
the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim
Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-june-2017-investor-conferences-300468729.html
SOURCE Vanda Pharmaceuticals Inc.